Skip to main content
Stephen Clark, MD, Neurology, San Francisco, CA

StephenWesleyClarkMDPhD, MSCI

Neurology San Francisco, CA

Chief Medical Officer, Epiphany Biosciences

Dr. Clark is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Clark's full profile

Already have an account?

Education & Training

  • Vanderbilt University
    Vanderbilt University MSCI, Master's of Science in Clinical Investigation, 2014 - 2016
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Neuro-Oncology, 2010 - 2011
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Neurology, 2007 - 2010
  • East Tennessee State University/Quillen College of Medicine
    East Tennessee State University/Quillen College of MedicineResidency, Internship, 2006 - 2007
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterInternship, Pathology-Anatomic and Clinical, 2005 - 2006
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 2005

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2010 - 2024
  • TN State Medical License
    TN State Medical License 2011 - 2024
  • American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Cannabis Usage Furthers the Risk of Delayed Cerebral Ischemia
    Cannabis Usage Furthers the Risk of Delayed Cerebral IschemiaJanuary 7th, 2022
  • Combined Modality Therapy Superior in Glioblastoma
    Combined Modality Therapy Superior in GlioblastomaMay 24th, 2016
  • Potential treatment for a subtype of glioblastoma tumors.
    Potential treatment for a subtype of glioblastoma tumors. June 11th, 2022
  • Join now to see all